[Featured Stock] Green Life Sciences, hits the limit up after signing a 10 billion won AI semiconductor material supply contract

robot
Abstract generation in progress

Green Life Sciences surged after news that it has signed an AI semiconductor materials supply contract worth 10.05 billion Korean won.

According to information from the Korea Exchange, Green Life Sciences briefly touched the daily limit-up price during intraday trading, closing at 3,645 Korean won. The sharp jump in the stock price is seen as being driven by investor sentiment boosted by the announcement of a large-scale supply contract targeting its affiliate company, Green Chemical.

The announcement shows the contract value is 10.05 billion Korean won, equivalent to 24.91% of its standalone benchmark sales of 40.3 billion Korean won in 2025. The contract runs from May 18 to December 31, 2026, with the supply area being domestic. The company said the quantity and amount will be determined based on the receipt of customer orders.

The market is paying close attention to the contract, viewing it as a sizable single-supply agreement. The contract is about one quarter of its sales, and as it supplies AI semiconductor materials, the related growth expectations are reflected in the impact on the stock price.

Previously, Green Life Sciences was a company based on precision chemical technology, developing and producing pharmaceutical ingredient materials, electronic materials, and crop protection agents. Founded in 2005, it listed on the KOSDAQ market in 2009. It was the first in South Korea to develop the piperacillin-class antibiotic intermediate EDP-CL and became the first domestic synthesis plant to receive U.S. FDA approval.

The contract is also interpreted as a case of achieving supply results in the electronic materials sector by leveraging its existing strengths in precision chemical technology.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin